Back
UroGen Pharma Vs. Protalix BioTherapeutics Industry Stock Comparison
Buy
53
URGN
UroGen Pharma
Last Price:
12.93
Seasonality Move:
13.95%
Buy
51
PLX
Protalix BioTherapeutics
Last Price:
1.20
Seasonality Move:
-7.33%
Buy
53
UroGen Pharma (URGN)
is a Buy
Is UroGen Pharma a Buy, Sell or Hold?
- The current UroGen Pharma [URGN] share price is $12.91. The Score for URGN is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- URGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.20. The Score for PLX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
URGN Stock Price Chart
What is UroGen Pharma's stock price today?
-
The UroGen Pharma share price today is $12.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing selling pressure, which indicates risk of future bearish movement.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.20
The current trend is relatively stagnant and PLX is experiencing buying pressure, which is a positive indicator for future bullish movement.
URGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 40.62 | Sell |
| Chaikin Money Flow: | -161197 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.2 - 14.32) | Sell |
| Bollinger Bands (100): | (13.54 - 17.22) | Sell |
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 51.73 | Buy |
| Chaikin Money Flow: | 389149 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.13 - 1.19) | Buy |
| Bollinger Bands (100): | (1.19 - 1.59) | Sell |
URGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.11 | Sell |
| 20-day SMA: | 13.65 | Sell |
| 50-day SMA: | 14.29 | Sell |
| 200-day SMA: | 15.17 | Sell |
| 8-day EMA: | 13.22 | Sell |
| 20-day EMA: | 13.55 | Sell |
| 50-day EMA: | 14.28 | Sell |
| 200-day EMA: | 14.34 | Sell |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.16 | Buy |
| 20-day SMA: | 1.16 | Buy |
| 50-day SMA: | 1.22 | Sell |
| 200-day SMA: | 1.52 | Sell |
| 8-day EMA: | 1.16 | Buy |
| 20-day EMA: | 1.17 | Buy |
| 50-day EMA: | 1.24 | Sell |
| 200-day EMA: | 1.47 | Sell |
UroGen Pharma Earnings Growth & URGN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.12 per share, a decrease this year of $0.03 per share, and an increase next year of $0.69 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
UroGen Pharma Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protalix BioTherapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||